![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
EW Karbon and SJ Enna
Baclofen and other gamma-aminobutyric acid B (GABAB) agonists potentiate the cyclic AMP response in rat brain slices that occurs during exposure to norepinephrine, isoproterenol, adenosine, vasoactive intestinal peptide, and histamine. By themselves the GABAB agonists have only a slight effect on basal cyclic AMP levels. Dose-response and time-course studies revealed that baclofen has little influence on neurotransmitter recognition site affinity, but rather enhances the synthesis or accumulation of second messenger that occurs in response to these agents. Baclofen appears to be neither an inhibitor of phosphodiesterases nor does it require adenosine to promote the response to other transmitters. The synergistic interaction between baclofen and catecholamines is a calcium-dependent process and is evident only in the rat brain cerebral cortex, hippocampus and corpus striatum, being undetectable in the pons-midbrain, cerebellum, and spinal cord. In contrast to the findings with neurotransmitter receptor stimulants, GABAB agonists inhibited the cyclic AMP response to forskolin. It remains unclear whether this action is related to the neurotransmitter potentiating effect of baclofen. These data suggest that GABAB agonists may modulate neurotransmitter receptor function by influencing a component of the cyclic nucleotide-generating system beyond the level of the hormone recognition site.
This article has been cited by other articles:
|
|
 |
|
  Y. Uezono, M. Kaibara, O. Murasaki, and K. Taniyama Involvement of G protein {beta}{gamma}-subunits in diverse signaling induced by Gi/o-coupled receptors: study using the Xenopus oocyte expression system Am J Physiol Cell Physiol, October 1, 2004; 287(4): C885 - C894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. A. Frere and A. Luthi Pacemaker channels in mouse thalamocortical neurones are regulated by distinct pathways of cAMP synthesis J. Physiol., January 1, 2004; 554(1): 111 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Bowery, B. Bettler, W. Froestl, J. P. Gallagher, F. Marshall, M. Raiteri, T. I. Bonner, and S. J. Enna International Union of Pharmacology. XXXIII. Mammalian gamma -Aminobutyric AcidB Receptors: Structure and Function Pharmacol. Rev., June 1, 2002; 54(2): 247 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Enna A GABAB Mystery: The Search for Pharmacologically Distinct GABAB Receptors Mol. Interv., October 1, 2001; 1(4): 208 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Jackson, S. G. Wood, and D. E. Kuehl A {gamma}-Aminobutyric AcidB Agonist Reverses the Negative Feedback Effect of Testosterone on Gonadotropin-Releasing Hormone and Luteinizing Hormone Secretion in the Male Sheep Endocrinology, November 1, 2000; 141(11): 3940 - 3945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Meldrum Classification of GABA and benzodiazepine receptors J Psychopharmacol, January 1, 1987; 1(1): 1 - 5. [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
